Skip to content

Effects of acute phase intensive exercise training in patients with acute decompensated heart failure: The ACTIVE-ADHF Randomized Controlled Trial

Effects of acute phase intensive exercise training in patients with acute decompensated heart failure: The ACTIVE-ADHF Randomized Controlled Trial - ACTIVE-ADHF Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000020919
Enrollment
135
Registered
2016-02-08
Start date
2016-06-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute decompensated heart failure

Interventions

1) Usual care 2) Supervised exercise therapy for 30-60 minutes per day, 5-7 days per week 3) Instruction of physical activity 1) Usual care

Sponsors

Kitasato University Hospital
Lead Sponsor
Kitasato University Medical Center, Kameda Medical Center
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients who were hospitalized for acute exacerbation of heart failure 2) Aged 30 years or older

Exclusion criteria

Exclusion criteria: 1) BNP < 100 pg/ml at admission 2) Cognitive dysfunction 3) Acute coronary syndrome 4) Significant myocardial ischemia during low-intensity exercise 5) Resting heart rate > 120/min 6) Acute infective endocarditis, myocarditis, and pericaritis 7) Presence of a recent hospitalization for heart failure (< 1 month) 8) Severe symptomatic aortic stenosis, mitral stenosis, and hypertrophic obstructive cardiomyopathy 9) Severe pulmonary hypertension 10) Intracardiac thrombus 11) Untreated life-threatening arrhythmia 12) Resting blood pressure > 180 mmHg 13) Ongoing orthopnea 14) Requiring high inotropic support 15) Patients with circulatory assist device 16) Patients with inadequate oxygenation 17) Patients with mechanical ventilation 18) History of aortic dissection, or presence of aortic aneurysm or aortic dissection 19) Patients with uncontrolled diabetes 20) Peripheral arterial disease (Fontain 3-4) 21) Recent embolism 22) Patients undergoing hemodialysis 23) Serum creatinine > 3.0 mg/dl 24) Severe anemia 25) Short life expectancy due to advanced disease other than heart failure 26) Patients who needed assistance for walking a month before hospitalization 27) Pregnant, lactational woman, patients may be pregnant

Design outcomes

Primary

MeasureTime frame
Six-minute walk distance [Time Frame: Measured at baseline and 2 weeks]

Secondary

MeasureTime frame
Lower extremity function, Physical activity, Cardiac and renal function, Quality of life [Time Frame: Measured at baseline and 2 weeks] Mortality and rehospitalization rates (measured at 30 days and 3 months) [Time Frame: Measured as events occur during the lifespan of the trial] Subgroup analysis (Statistical significance level of p-value for interaction: <0.1): Age >=65 years, Gender, LVEF >=50%, Six-minute walk distance >median value

Countries

Japan

Contacts

Public ContactKentaro Kamiya

Kitasato University Hospital Rehabilitation

kamiken.pt@gmail.com042-778-8413

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026